The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The launch coincides with IBS Awareness Month in April
Move to accelerate cancer care expansion across India
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
